narcotic antagonists

Preferred Label : narcotic antagonists;

MeSH definition : Agents inhibiting the effect of narcotics on the central nervous system.;

MeSH synonym : antagonists, narcotic; opioid antagonists; antagonists, opioid; Opioid Receptor Antagonists; Antagonists, Opioid Receptor; Receptor Antagonists, Opioid; Narcotic Antagonist; Antagonist, Narcotic; Opioid Receptor Antagonist; Antagonist, Opioid Receptor; Receptor Antagonist, Opioid; Opioid Antagonist; Antagonist, Opioid;

MeSH hyponym : Competitive Opioid Antagonists; Antagonists, Competitive Opioid; Opioid Antagonists, Competitive; Competitive Opioid Antagonist; Antagonist, Competitive Opioid; Opioid Antagonist, Competitive;

Related MeSH term : Agents, Opioid Reversal; Reversal Agents, Opioid; Opioid Reversal Agent; Agent, Opioid Reversal; Reversal Agent, Opioid;

MeSH annotation : DF: NARCOTIC ANTAG;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D009292;

UMLS CUI

C0027410;

ATC code(s)
- nalorphine [ATC Code]
- naloxone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Narcotic antagonist [ICHI extension code]
- Opioid antagonist [ICD-11 Extension code]
- Opioid receptor antagonist (disposition) [SNOMED CT concept]
- Opioid receptor antagonists [ICD-10 Sub-category (who)]
- Opioid receptor antagonists [ICHI section]
Currated CISMeF NLP mapping
- Narcotic antagonist [ICD-11 Extension code]
- Opiate Antagonist [NCIt concept]
- Opioid receptor antagonists [Bloc CIM-11]
- Product containing opioid receptor antagonist (product) [SNOMED CT concept]
- Substance with opioid receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 3-(8-(2-(cyclohexylmethyl(2,3-dihydroxypropionyl)amino)ethyl)-8-azabicyclo(3.2.1)oct-3-yl)benzamide [MeSH Supplementary Concept]
- 5-(3-hydroxyphenyl)-2-phenethyl-2-azabicyclo(3.3.1)nonan-4-ol [MeSH Supplementary Concept]
- LY2196044 [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- narcotics [MeSH Descriptor]
- receptors, opioid [MeSH Descriptor]
Record concept(s)
- Competitive Opioid Antagonists [MeSH concept]
- Opioid Reversal Agents [MeSH concept]
- narcotic antagonists [MeSH concept]
See also
- drug antagonism [MeSH Descriptor]
See also (suggested by CISMeF)
- narcotics [MeSH Descriptor]
See also inter- (CISMeF)
- Opioid receptor antagonists [ICD-10 Sub-category (who)]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(1-cyclooctylmethyl-5-(1-hydroxy-1-methylethyl)-1,2,3,6-tetrahydropyridin-4-yl)-3-ethyl-1,3-dihydrobenzoimidazol-2-one [MeSH Supplementary Concept]
- 17-(2-methyl-2-propenyl)-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7-2,3-indolomorphinan [MeSH Supplementary Concept]
- 17-(cyclopropylmethyl)-6,7-didehydro--13,14-dihydroxy-5'-(2-(2-pyridinyl)ethenyl)indolo(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-13,14-dihydroxy-7'-phenoxyindolo(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 7-benzylidenenaltrexone [MeSH Supplementary Concept]
- ALKS-33 [MeSH Supplementary Concept]
- Aticaprant [MeSH Supplementary Concept]
- Buprenorphine, Naloxone Drug Combination [MeSH Descriptor]
- ICI 154129 [MeSH Supplementary Concept]
- MR 2266 [MeSH Supplementary Concept]
- N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine [MeSH Supplementary Concept]
- N-methyl-9-methyl-5-(3-hydroxyphenyl)morphan [MeSH Supplementary Concept]
- N-phenethyl-9-methyl-5-(3-hydroxyphenyl)morphan [MeSH Supplementary Concept]
- beta-funaltrexamine [MeSH Supplementary Concept]
- buprenorphine [MeSH Descriptor]
- butorphanol [MeSH Descriptor]
- chlornaltrexamine [MeSH Supplementary Concept]
- clocinnamox [MeSH Supplementary Concept]
- connective tissue-activating peptide [MeSH Supplementary Concept]
- cyclazocine [MeSH Descriptor]
- diprenorphine [MeSH Descriptor]
- levallorphan [MeSH Descriptor]
- lofexidine [MeSH Supplementary Concept]
- meptazinol [MeSH Descriptor]
- methylnaltrexone [MeSH Supplementary Concept]
- mr 1452 [MeSH Supplementary Concept]
- nalbuphine [MeSH Descriptor]
- nalmefene [MeSH Supplementary Concept]
- nalorphine [MeSH Descriptor]
- naloxegol [MeSH Supplementary Concept]
- naloxone [MeSH Descriptor]
- naltrexone [MeSH Descriptor]
- naltrindole [MeSH Supplementary Concept]
- naltrindole benzofuran [MeSH Supplementary Concept]
- nociceptin (1-13)-NH2, Phe(1)-psi(CH2-NH)-Gly(2)- [MeSH Supplementary Concept]
- norbinaltorphimine [MeSH Supplementary Concept]
- pentazocine [MeSH Descriptor]
- phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide [MeSH Supplementary Concept]
- quadazocine [MeSH Supplementary Concept]
- tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Narcotic antagonist [ICD-11 Extension code]
- Narcotic antagonists [LOINC hierarchical part]
- Opiate Antagonist [NCIt concept]
- Opiate antagonists [ICD-11 Extension code]
- Opioid receptor antagonists [Bloc CIM-11]
- Product containing opioid receptor antagonist (product) [SNOMED CT concept]
- Substance with opioid receptor antagonist mechanism of action (substance) [SNOMED CT concept]
- opiate antagonist, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients